GR74749B - - Google Patents

Info

Publication number
GR74749B
GR74749B GR67456A GR820167456A GR74749B GR 74749 B GR74749 B GR 74749B GR 67456 A GR67456 A GR 67456A GR 820167456 A GR820167456 A GR 820167456A GR 74749 B GR74749 B GR 74749B
Authority
GR
Greece
Prior art keywords
image
group
products
formula
acid
Prior art date
Application number
GR67456A
Other languages
English (en)
Inventor
B Labeeuw
Ali Sahli
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of GR74749B publication Critical patent/GR74749B/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Train Traffic Observation, Control, And Security (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
GR67456A 1981-03-03 1982-03-02 GR74749B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8104243A FR2501209B1 (fr) 1981-03-03 1981-03-03 Nouveaux derives des cephalosporines et medicaments antibiotiques contenant lesdits derives

Publications (1)

Publication Number Publication Date
GR74749B true GR74749B (el) 1984-07-11

Family

ID=9255827

Family Applications (1)

Application Number Title Priority Date Filing Date
GR67456A GR74749B (el) 1981-03-03 1982-03-02

Country Status (18)

Country Link
US (1) US4476123A (el)
EP (1) EP0060745B1 (el)
JP (1) JPS57158791A (el)
AT (1) ATE18403T1 (el)
AU (1) AU559122B2 (el)
CA (1) CA1191838A (el)
DE (1) DE3269543D1 (el)
DK (1) DK88382A (el)
ES (1) ES8305371A1 (el)
FI (1) FI73441C (el)
FR (1) FR2501209B1 (el)
GR (1) GR74749B (el)
IE (1) IE52767B1 (el)
IL (1) IL65110A (el)
NO (1) NO820649L (el)
NZ (1) NZ199875A (el)
PT (1) PT74511B (el)
ZA (1) ZA821365B (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507487A (en) * 1982-09-23 1985-03-26 Bristol-Myers Company Chemical compounds
EP0115770B2 (en) * 1983-01-07 1996-06-19 Takeda Chemical Industries, Ltd. Thiazole Derivatives
FR2546520B1 (fr) * 1983-05-27 1985-08-30 Sanofi Sa Nouveaux composes antibiotiques derives des cephalosporines
FR2570702B1 (fr) * 1984-09-27 1987-01-09 Sanofi Sa Derives des cephalosporines, procedes d'obtention et leur application a titre d'antibiotiques
US4665066A (en) * 1984-12-24 1987-05-12 Eli Lilly And Company 3-thiazolomethyl cephalosporins as antibiotics
US5359057A (en) * 1986-02-07 1994-10-25 Hoffmann-La Roche Inc. Acylation of amines
ZA874696B (en) * 1986-07-03 1988-01-04 F. Hoffmann-La Roche & Co. Aktiengesellschaft Acyl derivatives
US5147871A (en) * 1986-07-03 1992-09-15 Hoffmann La-Roche, Inc. Anti-bacterial cephalosporin compounds
US5336768A (en) * 1988-05-24 1994-08-09 Hoffmann-La Roche Inc. Antibacterial cephalosporin compounds
CS273349B2 (en) * 1988-03-31 1991-03-12 Hoffmann La Roche Method of cephalosporin's new derivatives production
GB8907617D0 (en) * 1989-04-05 1989-05-17 Celltech Ltd Drug delivery system
US5162523A (en) * 1989-07-21 1992-11-10 Hoffmann-La Roche Inc. Cephalosporin antibacterial compounds
US5159077A (en) * 1989-07-21 1992-10-27 Hoffmann-La Roche Inc. Penam antibacterial compounds
US5318781A (en) * 1993-04-06 1994-06-07 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5919114B2 (ja) * 1975-08-25 1984-05-02 武田薬品工業株式会社 セフアロスポリンの製造法
US4165430A (en) * 1976-03-19 1979-08-21 Glaxo Laboratories Limited Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group
DE2716677C2 (de) * 1977-04-15 1985-10-10 Hoechst Ag, 6230 Frankfurt Cephemderivate und Verfahren zu ihrer Herstellung
US4237128A (en) * 1979-04-12 1980-12-02 E. R. Squibb & Sons, Inc. 7-[2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1,1-dialkyl)alkoxyimino]acetamido]cephem sulfoxides
GR75644B (el) * 1980-06-18 1984-08-02 Fujisawa Pharmaceutical Co

Also Published As

Publication number Publication date
JPS57158791A (en) 1982-09-30
EP0060745A3 (en) 1983-08-31
AU559122B2 (en) 1987-02-26
CA1191838A (en) 1985-08-13
NZ199875A (en) 1985-04-30
DE3269543D1 (en) 1986-04-10
ZA821365B (en) 1983-01-26
IE52767B1 (en) 1988-02-17
EP0060745B1 (fr) 1986-03-05
DK88382A (da) 1982-09-04
IL65110A0 (en) 1982-04-30
FR2501209B1 (fr) 1986-07-04
FI73441C (fi) 1987-10-09
US4476123A (en) 1984-10-09
PT74511A (fr) 1982-04-01
NO820649L (no) 1982-09-06
ES510068A0 (es) 1983-04-01
ATE18403T1 (de) 1986-03-15
ES8305371A1 (es) 1983-04-01
IE820463L (en) 1982-09-03
IL65110A (en) 1985-02-28
EP0060745A2 (fr) 1982-09-22
FI820736L (fi) 1982-09-04
AU8106182A (en) 1982-09-09
FR2501209A1 (fr) 1982-09-10
PT74511B (fr) 1983-11-08
FI73441B (fi) 1987-06-30

Similar Documents

Publication Publication Date Title
IE820463L (en) Cephalosporins
YU253782A (en) Process for obtaining new pyridinium - thiomethy cephalosporin derivatives
IL65232A (en) Beta-lactam acetic acid derivatives,process for preparing them and their use as intermediates for 1-azabicyclo(3.2.0)-hept-2-ene antibiotics
AU564235B2 (en) 3-heterocyclicthiomethy-cephen compounds
YU149683A (en) Process for obtaining cephalosporins